1. Home
  2. MRAM vs ANVS Comparison

MRAM vs ANVS Comparison

Compare MRAM & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Everspin Technologies Inc.

MRAM

Everspin Technologies Inc.

HOLD

Current Price

$18.46

Market Cap

353.8M

Sector

Technology

ML Signal

HOLD

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

HOLD

Current Price

$1.31

Market Cap

76.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRAM
ANVS
Founded
2008
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
353.8M
76.6M
IPO Year
2016
2019

Fundamental Metrics

Financial Performance
Metric
MRAM
ANVS
Price
$18.46
$1.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
★ $18.50
$13.50
AVG Volume (30 Days)
751.1K
★ 1.3M
Earning Date
04-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 39.39
EPS
★ N/A
N/A
Revenue
★ $49,417,000.00
N/A
Revenue This Year
$10.22
N/A
Revenue Next Year
$7.38
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 37.51
N/A
52 Week Low
$7.35
$1.04
52 Week High
$51.50
$5.50

Technical Indicators

Market Signals
Indicator
MRAM
ANVS
Relative Strength Index (RSI) 60.14 43.69
Support Level $15.60 $1.04
Resistance Level $19.00 $2.43
Average True Range (ATR) 0.93 0.09
MACD 0.36 0.03
Stochastic Oscillator 90.30 76.79

Price Performance

Historical Comparison
MRAM
ANVS

About MRAM Everspin Technologies Inc.

Everspin Technologies Inc is a manufacturer of Magnetoresistive Random Access Memory (MRAM) technology. The company manufactures MRAM products using both captive and third-party manufacturing capabilities. It purchases industry-standard complementary metal-oxide semiconductor (CMOS) wafers from semiconductor foundries and perform back end of line (BEOL) processing that includes magnetic-bit technology at leased 200mm fabrication facility in Chandler, Arizona. It also manufactures full-flow 300mm CMOS wafers with STT-MRAM magnetic-bit technology integrated in BEOL. The company's customers are in key markets, such as industrial, medical, automotive/transportation, aerospace, and data center.

About ANVS Annovis Bio Inc.

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

Share on Social Networks: